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REVUE DE LA LITTÉRATURE / LITERATURE REVIEW

Médecine Orale / Oral Medicine

DENTAL MANAGEMENT OF DIABETIC PATIENTS:
A CLINICAL REVIEW
Sunita Malik * | Gurdarshan Singh **
Abstract
Diabetes describes a group of metabolic diseases resulting from impaired insulin secretion, varying degrees of insulin resistance,
or both. Management of the diabetic dental patients must take into consideration the impact of dental disease and dental treatment
on the management of diabetes as well as an appreciation for the comorbidities that accompany long-standing diabetes. Those
comorbidities include obesity, hypertension and dyslipidemia. Management of the diabetic dental patient should focus on periodontal
health and the delivery of comprehensive dental care with minimal disruption of metabolic homeostasis and recognition of diabetic
comorbidities.
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PRISE EN CHARGE DES PATIENTS DIABÉTIQUES:
UNE REVUE CLINIQUE
Résumé
Le diabète est une maladie chronique du métabolisme qui apparaît lorsque le pancréas ne produit pas suffisamment d’insuline ou
que l’organisme n’utilise pas correctement l’insuline qu’il produit. La prise en charge des patients diabétiques au cabinet dentaire
doit prendre en considération l’impact des maladies dentaires et des soins dentaires sur le contrôle du diabète, ainsi qu’une appréciation des comorbidités qui accompagnent le diabète. Ces comorbidités sont l’obésité, l’hypertension et la dyslipidémie. La prise
en charge du patient diabétique devrait donc se concentrer sur la santé parodontale et la prestation des soins dentaires complets
sans perturber l’homéostasie métabolique.
Mots-clés: diabéte – hyperglycémie – rétinopathie – maladie macrovasculaire.
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Introduction
Diabetes mellitus (DM) is a group
of metabolic diseases characterized by
hyperglycemia resulting from defects
in insulin secretion, insulin action or
both. The chronic hyperglycemia of
diabetes is associated with long-term
damage, dysfunction and failure of
various organs, especially the eyes,
kidneys, nerves, heart and blood vessels [1].
DM results when one of the following conditions occurs: insulin
released from the pancreas is impaired
or insulin action at peripheral tissues
is impaired [2].
A deficiency in insulin or a problem
with its metabolic activity can result in
an increased blood glucose level (ie,
hyperglycemia). Hyperglycemia leads
to an increase in the urinary volume
of glucose and fluid loss, which then
produces dehydration and electrolyte
imbalance [3]. This latter problem, if
severe, may result in coma.
The stress of the disease also
results in an increase in cortisol secretion. It is the inability of the diabetic
patient to metabolize and use glucose,
the subsequent metabolism of body
fat, and the fluid loss and electrolyte
imbalance that causes metabolic acidosis. It is the hyperglycemia and ketoacidosis coupled with vascular wall
disease (microangiopathy and atherosclerosis) that alters the body’s ability
to manage infection and heal [3].
Based on the pathogenic processes, four types of diabetes are identified [4]:
• Type 1 diabetes: 5% of diabetics.
• Type 2 diabetes: 90% of diabetics.
• Gestational diabetes.
• Other: caused by various metabolic disorders, drugs or surgery.
The onset of symptoms is rapid
in type 1 diabetes, and includes the
classic triad of polyphagia, polydipsia
and polyuria, as well as weight loss,
irritability, drowsiness and fatigue [4].
Symptoms of type 2 diabetes develop
more slowly, and frequently without
the classic triad; rather, these patients
may be obese and may have pruritus,

peripheral neuropathy and blurred
vision. Opportunistic infections, including oral and vaginal candidiasis, can
be present. Adults with long-standing
diabetes, especially those with poorly
controlled hyperglycemia, may develop microvascular and macrovascular
conditions that can produce irreversible damage to the eyes (retinopathy, cataracts), kidneys (nephropathy), nervous system (neuropathy and
paresthesias), and heart (accelerated
atherosclerosis), as well as recurrent infections and impaired wound
healing.
Gestational DM is defined as any
degree of glucose intolerance with
onset or first recognition during pregnancy [5]. In the majority of cases,
glucose regulation will return to normal after delivery.
Diabetes and the oral manifestations
Several soft tissue abnormalities
have been reported to be associated with diabetes mellitus in the oral
cavity.
Xerostomia and dry mouth
Dry mouth is a common complaint
among diabetic patients. This can be
due to hyperglycemia, which leads to
polyuria and can result in a lowering of
fluids like saliva [6]. Xerostomia may
also be a side effect of other medications such as antihistamines.
Xerostomia disrupts the normal
saliva balance in the mouth, which
leads to a number of oral and dental disorders such changes in taste,
speech, and the ability to eat in addition to increasing the risk of cavities
and infections [7]. Xerostomia also
causes mouth tissues to become inflamed and sore, which in turn can make
chewing, tasting and swallowing difficult and possibly lead to difficulties
in controlling diabetes because of a
reduced interest in eating and thus, an
inability to properly maintain stable
blood sugar levels.
Caries
Due to the low sugar diets followed
by most DMs, many do not have a lot

of carious lesions, restorations, or enamel decalcification [8]. Exceptions are
the cervical caries noted in type 2 DM
with high sugar diets, those that drink
soft drinks, and those with xerostomia.
If the patient also has oral fungal infections, the topical antifungal medications have high sugar content and can
promote caries.
Candidiasis
Another manifestation of diabetes and an oral sign of systemic
immunosuppression is the presence
of opportunistic infections, such as
oral candidiasis. Fungal infections
of oral mucosal surfaces and removable prostheses are more commonly
found in adults with diabetes. Candida
Pseudohyphae, a cardinal sign of oral
Candida infection, have been associated significantly with cigarette smoking, use of dentures and poor glycemic control in adults with diabetes
[9]. Salivary hypofunction also may
increase the oral candidal carriage
state in adults with diabetes [10].
Periodontal disease
Large number of investigations
have provided the evidence that type
1 and type 2 diabetes increase the risk
and severity of periodontitis [11, 12],
and vice versa periodontitis has been
shown to have impact on diabetic status by using rodent studies although
the underlying mechanism has not
been discussed [13]. The association
between diabetes mellitus and periodontal disease is therefore considered
to be bidirectional: diabetes as a risk
factor for periodontitis and periodontitis as a possible severity for diabetes.
In fact, aggressive periodontitis is
recognized as the sixth serious complication of diabetes [14].
Treatment of periodontal disease
in DMs is similar to treatment in
non-DMs. One major difference is the
strong collaboration required by the
dental professional with the patient’s
medical caregivers. Studies showed
that there can be a temporary increase
in the control of DM when periodontal disease is controlled. Proper oral
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hygiene care may arrest periodontal
disease if treatment is aimed at daily
plaque removal and timely calculus
removal [15].
Taste disturbances
Taste is a critical component of
oral health that is affected adversely in
patients with diabetes [16]. One study
reported that more than one-third of
adults with diabetes had hypogeusia
or diminished taste perception, which
could result in hyperphagia and obesity [17]. This sensory dysfunction can
inhibit the ability to maintain a proper diet and can lead to poor glycemic
regulation.
Other oral manifestations include
oral lichen planus, trigeminal neuralgia, traumatic ulcers and irritation
fibromas.
Dental management considerations
Diabetes mellitus is not a curable
disease. Any patient who has cardinal symptoms of diabetes (polydypsia, polyuria, polyphagia, weight loss,
weakness) but has not been diagnosed,
should be referred to a physician for
diagnosis and treatment.
To minimize the risk of intraoperative emergency, clinicians need to
consider a number of issues before
initiating the dental treatment [Lalla].
Medical history
It’s important for clinicians to take
a good medical history at the first
appointment. They should ask patients
about recent blood glucose levels and
frequency of hypoglycemic episodes,
as well as the antidiabetic medications, their dosage and their times of
administration [5].
Blood glucose monitoring
Depending on the patient’s medical history, medication regimen and
procedure to be performed, dentists
may need to measure the blood glucose level before beginning any procedure, especially to prevent the risk of
a hypoglycemic event [5].

For glycemic control, it is recommended that the HbA1c level (monitored every three months) be maintained at less than 7 percent. If daily
blood glucose monitoring is performed, fasting blood plasma levels
should be less than 120 mg/dl and
blood glucose levels two hours postprandial should be less than 150 mg/
dl. For every 1 percent HbA1c level,
there is an associated increase in complication rates for both microvascular
and macrovascular diseases.
Also, elective procedures should
be postponed if the fasting glucose is
either less than 70 mg/dl. It has been
emphasized that when blood glucose
level is less than 70 mg/dl, there is risk
of hypoglycemia [18].
Antibiotic coverage
Patients with poorly controlled
diabetes are at risk of developing oral
complications because of their susceptibility to infection and sequelae,
and likely will require supplemental
antibiotic therapy [19]. Anticipation
of dentoalveolar surgery (involving
mucosa and bone) with antibiotic
coverage may help prevent impaired
and delayed wound healing. Orofacial
infections require close monitoring.
Cultures should be performed for acute
oral infections, antibiotic therapy initiated and surgical therapies contemplated if appropriate (for example,
incision and drainage, extraction, pulpectomy). In cases of poor response to
the first antibiotic administered, dentists can select a more effective antibiotic based on the patient’s sensitivity test results.
Diet
Dental treatment can result in postoperative discomfort. This may necessitate changes in the diet, especially in
cases of extensive dental therapy [5].
Because diet is a major component
of diabetes management, diet alterations that are made because of dental
treatment may have a major impact on
the patient. The clinician may need to
consult the patient’s physician prior to
therapy, to discuss diet modifications

and required changes in medication
regimens. Another diet change occurs
when patients are placed on orders to
take nothing by mouth (NPO) before
dental treatment, a common recommendation before conscious sedation.
Consultation with the patient’s physician may be needed to adjust the dose
of insulin or oral agents in this situation [5]. Physicians often recommend
reducing the insulin dose that immediately precedes lengthy or extensive
dental procedures.
Scheduling considerations for
diabetic dental patients
Morning appointments are recommended, preferably 11/2 hours after
breakfast and morning meds to avoid
the peak action time for those who take
insulin injections and since the endogenous cortisol levels are generally
higher at this time. Do not schedule
appointments during lunch breaks
or as the last appointment of the day
before dinner since blood sugar levels
can be low and oral health care procedures can interfere with eating. In
the case of type 1, ask the patient to
bring their own monitoring device to
the appointment to monitor their glucose if there is any question as to their
control.
For patients who take insulin, the
greatest risk of hypoglycemia will thus
occur about 30 to 90 minutes after
injecting lispro insulin, 2 to 3 hours
after regular insulin, and 4 to 10 hours
after NPH or Lente insulin. For those
who are taking oral sulfonylureas,
peak insulin activity depends on the
individual drug taken. Metformin and
the thiazolidinediones rarely cause
hypoglycemia.
For the above mentioned reasons,
it‘s advised to avoid dental appointments when the patient:
• Has not had meds or eaten
• Has cold, or flu, or tiredness
•
Has not recently seen their
physician
• Has levels <70 mg/dl or >150 mg/
dl
• Has had a recent emergency.
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Management of potential
complications
Certain patients may need a medical consult before elective dental treatment [20]. Many of them may have
complications such as cardiovascular
disease, renal disease, blindness, or
side effects from related medications.
It is vital for the dental professional
to always be prepared for emergency
situations and immediately control
any serious oral infections.
Hypoglycaemia
The most common complication
of diabetic mellitus that can occur in
the dental office is a hypoglycemic
episode [21]. If insulin or oral antidiabetic drug levels exceed physiological
needs, the patient may experience a
severe decline in his or her blood sugar
level. The maximal risk of developing
hypoglycemia generally occurs during
peak insulin activity. Initial signs and
symptoms include mood changes,
decreased spontaneity, hunger and
weakness. These may be followed
by sweating, incoherence and tachycardia. If untreated, possible consequences include unconsciousness,
hypotension, hypothermia, seizures,
coma and death.
Preventing such complication
requires:
•
Thorough medical history and
consultation with physician to
assess glycemic control, disease
severity and medications with
hypoglycemic potential.
•Monitoring of the blood glucose
level and the dietary intake before
treatment.
•Avoidance of peak activity periods
of insulin or oral antidiabetic
medications.
•
Recognition of signs and symptoms of low blood glucose level
and timely administration of carbohydrate source (oral, intramuscular, intravenous)
 alivary gland dysfunction and oral
S
burning
Salivary gland dysfunction might
play a role in the onset of the syn-

drome of burning mouth syndrome
(BMS). Radiation therapy, some systemic diseases, and a variety of pharmacologic agents [22], known to be
capable of inducing a decrease in salivary flow rate [23] have reportedly been
associated with increased incidence of
BMS [24].
BMS may represent a complex of
multiple diseases with overlapping
symptoms [25]. Consequently, dealing
with a syndrome which is poorly defined by symptom(s) without regard
to etiology actually causes more
problems relative to diagnosis and
management.
However, maintaining an adequate
oral hydration (saliva substitutes,
sugarless gums, water, ice chips) and
the restriction of caffeine and alcohol
intake can help reduce the symptoms
[26].
Infection and delayed wound healing
Wound infection is a major complication in diabetic patients [27].
Factors such as age, obesity, malnutrition, and macrovascular and microvascular diseases may contribute to
wound infection and delayed wound
healing especially in the type II diabetic patient. In addition, hyperglycemia
caused by decreased insulin availability and increased resistance to insulin
can affect the cellular response to tissue injury.
At the cellular level, an increase
in the number of acute inflammatory
cells, absence of cellular growth, and
migration of the epidermis have been
observed [28]. Patients with diabetes
have impaired leukocyte function, and
the metabolic abnormalities of diabetes lead to inadequate migration of
neutrophils and macrophages to the
wound, along with reduced chemotaxis
[29, 30]. Such cellular changes would
predispose individuals to an increased
risk of wound infection.
In order to prevent such complication, frequent dental visits may help to
control plaque formation and to identify risk factors for periodontal disease,
caries and oral candidiasis.

Conclusion
Managing the care of patients
with DM in the dental office should
not pose a significant challenge.
Hypoglycemia is the major issue that
usually confronts dental practitioners
when they are treating patients with
DM, especially if patients are asked to
fast before undergoing a procedure.
Finally, having well-controlled
blood glucose levels is important
for infection prevention and proper
healing. At the same time, patients
are needed to be made aware of regular periodontal maintenance schedule
and oral hygiene.
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